Toll‐like receptor (TLR) 2 and TLR4 are reported as biglycan receptors, and TEC‐biglycan facilitated TLR‐expressing tumor cell migration through the activation of NF‐κB and ERK signaling. The gene discussed is NFKB1; the disease is neoplasm.